Product Information
LATANOPROST 0.005% EYE DROPS is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.5751 per ML under NDC 68462094403. Its NADAC has been published 56 times since Sep 10, 2025.
FDA first approved this application on Nov 26, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
50 ug/mL
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462094403
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LATANOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA218257FDA Approved
11/26/2024
TE Code
AT
On Market Since
11/26/2024
Price Statistics
The NADAC for LATANOPROST 0.005% EYE DROPS has been published 56 times since Sep 10, 2025, and over the history we have for it it has declined 13.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5751 per ML |
|---|---|
| All-time high | $1.8338 (Jan 14, 2026) |
| All-time low | $1.5685 (Aug 19, 2026) |
| 52-week high | $1.8338 |
| 52-week low | $1.5685 |
| Median price | $1.6815 |
| Average price | $1.7015 |
| Largest weekly change | -4.9% (Apr 22, 2026) |
| Weeks tracked | 56 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
latanoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LATANOPROST 0.005% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for LATANOPROST 0.005% EYE DROPS, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.5751 per ML (NDC 68462094403), effective Sep 30, 2026.
How has the price of LATANOPROST 0.005% EYE DROPS changed over time?
Over the history we have for it, the NADAC for LATANOPROST 0.005% EYE DROPS has declined 13.6%. It has been tracked across 56 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for LATANOPROST 0.005% EYE DROPS?
Since Sep 10, 2025, the NADAC for LATANOPROST 0.005% EYE DROPS has ranged from a low of $1.5685 (Aug 19, 2026) to a high of $1.8338 (Jan 14, 2026), with a median of $1.6815 per ML.
Are there cheaper alternatives to LATANOPROST 0.005% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LATANOPROST 0.005% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures LATANOPROST 0.005% EYE DROPS?
LATANOPROST 0.005% EYE DROPS (NDC 68462094403) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.